New Delhi: Bharat Biotech International Ltd and Zydus Cadila Ltd have completed the phase I of clinical trials for their respective vaccine candidates against covid-19, just three weeks after the two companies started human dosing of the immunisation shots against the fatal respiratory disease, Indian Council of Medical Research director general Balram Bhargava said.“At the present moment, we have three vaccines in different levels of clinical testing.
The first one is the inactivated virus vaccine, which is the Bharat Biotech vaccine, which has completed its Phase I study in 11 sites, and has started its phase II study...